Reviewing Trinity Capital (NASDAQ:TRIN) & Prenetics Global (NASDAQ:PRE)

Trinity Capital (NASDAQ:TRIN – Get Rating) and Prenetics Global (NASDAQ:PRE – Get Rating) are both small-cap finance companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, dividends, risk, valuation, profitability and analyst recommendations.

Institutional and Insider Ownership

27.0% of Trinity Capital shares are held by institutional investors. Comparatively, 13.0% of Prenetics Global shares are held by institutional investors. 6.9% of Trinity Capital shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Trinity Capital and Prenetics Global, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Trinity Capital	1	3	1	0	2.00
Prenetics Global	0	0	2	0	3.00

Trinity Capital presently has a consensus target price of $15.55, suggesting a potential upside of 24.10%. Prenetics Global has a consensus target price of $7.00, suggesting a potential upside of 764.20%. Given Prenetics Global’s stronger consensus rating and higher possible upside, analysts clearly believe Prenetics Global is more favorable than Trinity Capital.

Risk & Volatility

Trinity Capital has a beta of 0.58, meaning that its stock price is 42% less volatile than the S&P 500. Comparatively, Prenetics Global has a beta of -0.59, meaning that its stock price is 159% less volatile than the S&P 500.

Valuation & Earnings

This table compares Trinity Capital and Prenetics Global’s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Trinity Capital	$145.50 million	3.01	-$30.38 million	($0.99)	-12.66
Prenetics Global	N/A	N/A	-$3.31 million	N/A	N/A

Prenetics Global has lower revenue, but higher earnings than Trinity Capital.

Profitability

This table compares Trinity Capital and Prenetics Global’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Trinity Capital	-20.88%	15.69%	6.69%
Prenetics Global	N/A	N/A	N/A

Summary

Trinity Capital beats Prenetics Global on 6 of the 11 factors compared between the two stocks.

About Trinity Capital

(Get Rating)

Trinity Capital Inc. is a business development company. It is a venture capital firm specializing in venture debt to growth stage companies looking for loans and/or equipment financing. Trinity Capital Inc. was founded in 2019 is based in Phoenix, Arizona with additional offices in Lutherville-Timonium, Maryland, San Diego, California and Austin, Texas.

About Prenetics Global

(Get Rating)

Prenetics Global Limited, an investment holding company, operates as a diagnostics and genetic testing company. Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring system that allows users to take COVID-19 tests at point-of-care or at home utilizing the nucleic acid amplification test. The company's products also comprise ColoClear, a non-invasive FIT-DNA colorectal cancer screening test; Circle SnapShot, an off-the-shelf at-home blood test; Circle Medical, a diagnostic testing product; and Circle One and F1x/Fem. Prenetics Global Limited was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.